2,142
Views
0
CrossRef citations to date
0
Altmetric
Endocrinology

Protocol for a nested case-control study design for omics investigations in the Environmental Determinants of Islet Autoimmunity cohort

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & show all
Article: 2198255 | Received 06 Jan 2023, Accepted 27 Mar 2023, Published online: 12 Apr 2023

References

  • Penno MA, Couper JJ, Craig ME, et al. Environmental Determinants of Islet Autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr. 2013;13(1):1–12.
  • Krischer JP, Liu X, Lernmark Å, et al. Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study. Diabetes Care. 2022;45(10):2271–2281.
  • Rewers M, Bugawan T, Norris J, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39(7):807–812.
  • Group TS. The environmental determinants of diabetes in the young (TEDDY) study. Ann N Y Acad Sci. 2008;1150(1):1–13.
  • Peet A, Kool P, Ilonen J, et al. Birth weight in newborn infants with different diabetes-associated HLA genotypes in three neighbouring countries: Finland, Estonia and Russian Karelia. Diabetes Metab Res Rev. 2012;28(5):455–461.
  • Ziegler A-G, Hummel M, Schenker M, et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes. 1999;48(3):460–468.
  • Gillman MW. Developmental origins of health and disease. N Engl J Med. 2005;353(17):1848–1850.
  • Alcazar O, Hernandez LF, Nakayasu ES, et al. Parallel multi-omics in high-risk subjects for the identification of integrated biomarker signatures of type 1 diabetes. Biomolecules. 2021;11(3):383.
  • Li Q, Parikh H, Butterworth MD, et al. Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY study. Diabetes. 2020;69(3):465–476.
  • Lamichhane S, Ahonen L, Dyrlund TS, et al. Dynamics of plasma lipidome in progression to islet autoimmunity and type 1 diabetes–type 1 diabetes prediction and prevention study (DIPP). Sci Rep. 2018;8(1):10635.
  • Prentice RL. On the design of synthetic case-control studies. Biometrics. 1986;42(2):301–310.
  • Richardson D. An incidence density sampling program for nested case-control analyses. Occup Environ Med. 2004;61(12):e59.
  • Borgan Ø, Keogh R. Nested case–control studies: should one break the matching? Lifetime Data Anal. 2015;21(4):517–541.
  • Breslow NE. Statistics in epidemiology: the case-control study. J Am Stat Assoc. 1996;91(433):14–28.
  • Goldstein L, Langholz B. Asymptotic theory for nested case-control sampling in the cox regression model. Ann Statist. 1992;20(4):1903–1928.
  • Ngo LH, Inouye SK, Jones RN, et al. Methodologic considerations in the design and analysis of nested case-control studies: association between cytokines and postoperative delirium. BMC Med Res Methodol. 2017;17(1):1–10.
  • McGorm KJ, Brown JD, Thomson RL, et al. A long-term evaluation of Facebook for recruitment and retention in the ENDIA type 1 diabetes pregnancy-birth cohort study. J Diabet Sci Technol. 2022:19322968221079867.
  • Dupont WD. Power calculations for matched case-control studies. Biometrics. 1988;44(4):1157–1168.
  • R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020.
  • Stevenson M, Sergeant E. epiR: tools for the analysis of epidemiological data. 2022. R package version 2.0.48. https://CRAN.R-project.org/package=epiR
  • Guo Y, Logan HL, Glueck DH, et al. Selecting a sample size for studies with repeated measures. BMC Med Res Methodol. 2013;13(1):1–8.
  • Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. J Am Med Assoc. 2013;309(23):2473–2479.
  • Orban T, Sosenko JM, Cuthbertson D, et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial–type 1. Diabetes Care. 2009;32(12):2269–2274.
  • Dahlquist GG, Nyström L, Patterson CC. Incidence of type 1 diabetes in Sweden among individuals aged 0–34 years, 1983–2007: an analysis of time trends. Diabetes Care. 2011;34(8):1754–1759.
  • Maahs DM, West NA, Lawrence JM, et al. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481–497.
  • Lee HS, Burkhardt BR, McLeod W, et al. Biomarker discovery study design for type 1 diabetes in the environmental determinants of diabetes in the young (TEDDY) study. Diabetes Metab Res Rev. 2014;30(5):424–434.
  • Yeung W-CG, Al-Shabeeb A, Pang CNI, et al. Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile. Diabetes. 2012;61(6):1500–1508.
  • Vehik K, Lynch KF, Wong MC, et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med. 2019;25(12):1865–1872.
  • Lin IF, Paik MC. Matched case—control data analysis with selection bias. Biometrics. 2001;57(4):1106–1112.
  • Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16):9440–9445.
  • Lee HS, Lynch KF, Krischer JP. Nested case-control data analysis using weighted conditional logistic regression in the environmental determinants of diabetes in the young (TEDDY) study: a novel approach. Diabetes Metab Res Rev. 2020;36(1):e3204.
  • Ruiz-Perez D, Guan H, Madhivanan P, et al. So you think you can PLS-DA? BMC Bioinf. 2020;21(Suppl 1):2.
  • Balzano-Nogueira L, Ramirez R, Zamkovaya T, et al. Integrative analyses of TEDDY omics data reveal lipid metabolism abnormalities, increased intracellular ROS and heightened inflammation prior to autoimmunity for type 1 diabetes. Genome Biol. 2021;22(1):1–27.